The FDA is closer to approving a gene-editing treatment for sickle cell disease
The Food and Drug Administration took a crucial step toward approving the first treatment using the revolutionary gene-editing technique known as CRISPR to treat sickle cell disease.
Read more on NPR
Science - November 1, 2023 at 03:17AM - The FDA is closer to approving a gene-editing treatment for sickle cell disease
Không có nhận xét nào:
Đăng nhận xét